• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

停用含30微克炔雌醇和2毫克地诺孕素的口服避孕药后的生育力

Fertility after discontinuation of treatment with an oral contraceptive containing 30 microg of ethinyl estradiol and 2 mg of dienogest.

作者信息

Wiegratz Inka, Mittmann Katrin, Dietrich Horst, Zimmermann Thomas, Kuhl Herbert

机构信息

Department of Obstetrics and Gynecology, J. W. Goethe University, Frankfurt am Main, Germany.

出版信息

Fertil Steril. 2006 Jun;85(6):1812-9. doi: 10.1016/j.fertnstert.2005.11.052.

DOI:10.1016/j.fertnstert.2005.11.052
PMID:16759929
Abstract

OBJECTIVE

To examine the conception rate after cessation of a combination of 30 microg ethinyl E2 and 2 mg dienogest (EE/DNG).

DESIGN

Prospective observational study.

SETTING

Population-based cohort in Germany.

PATIENT(S): Women who wished to become pregnant after cessation of an oral contraceptive (EE/DNG).

INTERVENTION(S): None.

MAIN OUTCOME MEASURE(S): Cumulative conception rate within 1 year after termination of EE/DNG and time to pregnancy.

RESULT(S): After 1 year of follow-up, the cumulative pregnancy rate was 86.6% (full analysis set; n = 706). When all participants with complete data were analyzed (n = 652), the cumulative pregnancy rate was 94.0%. More than 15% of the patients conceived in each of the first three cycles after termination of EE/DNG; the mean time to pregnancy was 3.5 cycles. The preceding duration of treatment with EE/DNG did not influence the conception rate. Except in the youngest age group (16-18 years), a certain delay was observed in the other age groups.

CONCLUSION(S): The present prospective study revealed only a slight delay in regaining fertility during the first three cycles after cessation of EE/DNG. Thereafter, the cumulative rate of conception did not differ from that observed in fertile women who attempted to become pregnant without prior contraception.

摘要

目的

研究30微克炔雌醇E2与2毫克地诺孕素(EE/DNG)联合用药停药后的受孕率。

设计

前瞻性观察研究。

地点

德国基于人群的队列研究。

患者

口服避孕药(EE/DNG)停药后希望怀孕的女性。

干预措施

无。

主要观察指标

EE/DNG停药后1年内的累积受孕率及受孕时间。

结果

随访1年后,累积妊娠率为86.6%(全分析集;n = 706)。对所有有完整数据的参与者进行分析(n = 652)时,累积妊娠率为94.0%。超过15%的患者在EE/DNG停药后的前三个周期内受孕;平均受孕时间为3.5个周期。之前使用EE/DNG的治疗时长不影响受孕率。除最年轻年龄组(16 - 18岁)外,其他年龄组均观察到一定延迟。

结论

本前瞻性研究显示,EE/DNG停药后的前三个周期内恢复生育能力仅有轻微延迟。此后,累积受孕率与未事先避孕而试图怀孕的育龄妇女的受孕率无差异。

相似文献

1
Fertility after discontinuation of treatment with an oral contraceptive containing 30 microg of ethinyl estradiol and 2 mg of dienogest.停用含30微克炔雌醇和2毫克地诺孕素的口服避孕药后的生育力
Fertil Steril. 2006 Jun;85(6):1812-9. doi: 10.1016/j.fertnstert.2005.11.052.
2
Return to fertility after cessation of a continuous oral contraceptive.
Fertil Steril. 2009 May;91(5):1654-6. doi: 10.1016/j.fertnstert.2008.02.122. Epub 2008 May 7.
3
Effect of four oral contraceptives on hemostatic parameters.四种口服避孕药对止血参数的影响。
Contraception. 2004 Aug;70(2):97-106. doi: 10.1016/j.contraception.2004.03.004.
4
Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.含30微克炔雌醇和2毫克地诺孕素的口服避孕药常规或延长周期方案对各种止血参数的影响。
Contraception. 2008 Nov;78(5):384-91. doi: 10.1016/j.contraception.2008.06.015. Epub 2008 Sep 2.
5
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.含30微克炔雌醇和2毫克地诺孕素的口服避孕药对甲状腺激素和雄激素参数的影响:传统用法与延长周期用法对比
Contraception. 2008 Jun;77(6):420-5. doi: 10.1016/j.contraception.2008.02.005. Epub 2008 Apr 24.
6
Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.波兰炔雌醇/地诺孕素口服复方避孕药的临床研究结果。
Methods Find Exp Clin Pharmacol. 2002 Nov;24(9):585-92.
7
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.含0.030毫克炔雌醇/2毫克地诺孕素的复方口服避孕药与安慰剂及0.035毫克炔雌醇/2毫克醋酸环丙孕酮相比治疗丘疹脓疱型痤疮的疗效
Contraception. 2009 Apr;79(4):282-9. doi: 10.1016/j.contraception.2008.10.010. Epub 2008 Dec 16.
8
Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.生育与复方口服避孕药——口服避孕药使用后的意外妊娠和计划妊娠——INAS-SCORE研究结果
Eur J Contracept Reprod Health Care. 2017 Feb;22(1):17-23. doi: 10.1080/13625187.2016.1241991. Epub 2016 Oct 17.
9
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.静脉血栓栓塞风险与含地诺孕素和屈螺酮的口服避孕药的使用:一项德国病例对照研究的结果
J Fam Plann Reprod Health Care. 2010 Jul;36(3):123-9. doi: 10.1783/147118910791749416.
10
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].[低剂量口服避孕药的个体化。口服避孕药的药理学原理及实际应用指征]
Minerva Ginecol. 2007 Aug;59(4):415-25.

引用本文的文献

1
Potential biomarkers to predict return to fertility after discontinuation of female contraceptives-looking to the future.预测停用女性避孕药后恢复生育能力的潜在生物标志物——展望未来。
Front Reprod Health. 2023 Aug 22;5:1210083. doi: 10.3389/frph.2023.1210083. eCollection 2023.
2
Pregnancy resumption following contraceptive discontinuation: Hazard survival analysis of the Indonesia Demographic and Health Survey Data 2007, 2012 and 2017.避孕措施停止后妊娠的恢复:2007、2012 和 2017 年印度尼西亚人口与健康调查数据的危险生存分析。
PLoS One. 2022 Feb 23;17(2):e0264318. doi: 10.1371/journal.pone.0264318. eCollection 2022.
3
Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome.
走向使多囊卵巢综合征青春期女孩排卵率正常化的治疗方法。
J Endocr Soc. 2020 Mar 14;4(5):bvaa032. doi: 10.1210/jendso/bvaa032. eCollection 2020 May 1.
4
Return of fertility after discontinuation of contraception: a systematic review and meta-analysis.停用避孕措施后生育能力的恢复:一项系统评价与荟萃分析
Contracept Reprod Med. 2018 Jul 23;3:9. doi: 10.1186/s40834-018-0064-y. eCollection 2018.
5
History of oral contraceptive use and risk of spontaneous abortion.口服避孕药的使用史与自然流产风险
Ann Epidemiol. 2015 Dec;25(12):936-41.e1. doi: 10.1016/j.annepidem.2015.09.001. Epub 2015 Sep 14.
6
Pre-gravid oral contraceptive use and time to pregnancy: a Danish prospective cohort study.孕前口服避孕药使用与妊娠时间:丹麦前瞻性队列研究。
Hum Reprod. 2013 May;28(5):1398-405. doi: 10.1093/humrep/det023. Epub 2013 Feb 20.
7
Hormonal contraception--what kind, when, and for whom?激素避孕——哪种、何时、以及针对谁?
Dtsch Arztebl Int. 2011 Jul;108(28-29):495-505; quiz 506. doi: 10.3238/arztebl.2011.0495. Epub 2011 Jul 18.
8
Characteristics of the menstrual cycle after discontinuation of oral contraceptives.停用口服避孕药后月经周期的特点。
J Womens Health (Larchmt). 2011 Feb;20(2):169-77. doi: 10.1089/jwh.2010.2001. Epub 2011 Jan 10.
9
Ethinylestradiol/dienogest in oral contraception.炔雌醇/地诺孕素复方口服避孕药。
Drugs. 2010 Apr 16;70(6):681-9. doi: 10.2165/11536320-000000000-00000.
10
Lifestyle and reproductive factors associated with follicular phase length.与卵泡期长度相关的生活方式和生殖因素。
J Womens Health (Larchmt). 2007 Nov;16(9):1340-7. doi: 10.1089/jwh.2007.0354.